NPYR调制:肥胖和2型糖尿病管理的下一个重大进步的潜力?
Ryan A Lafferty1, Peter R Flatt1, Nigel Irwin1
1Diabetes Research Centre, Ulster University, Coleraine, Northern Ireland BT52 1SA, UK.
Peptides
|June 2, 2024
概括
神经Y家族,包括NPY,PYY和PP,显示出对肥胖和2型糖尿病的治疗前景. 需要进行结构性修改,以克服快速退化并提高其有效性.
科学领域:
- 代谢疾病 代谢疾病
- 内分泌学 在内分泌学.
- 类治疗药物 类治疗药物
背景情况:
- 类似葡萄糖类-1 (GLP-1) 的模仿剂,如西马格卢提德和利拉格卢提德,已被批准用于治疗肥胖和2型糖尿病 (T2DM).
- 蒂尔泽帕提德是一种双重的依赖葡萄糖的胰岛素型多 (GIP) 和GLP-1受体激动剂,提供了一个潜在的更耐受的选择.
- 非类类疗法正在出现,突出显示了对多样化治疗策略的需求.
研究的目的:
- 审查神经Y (NPY) 家族对代谢疾病的治疗潜力.
- 探索NPY,氨酸-氨酸 (PYY) 和胰腺多 (PP) 的代谢相关影响.
- 讨论修改这些的策略,以提高它们的治疗效用.
主要方法:
- 这是一个叙事综述,综合了NPY家族的现有研究.
- 该审查审查了NPY,PYY和PP的生理作用和潜在的治疗应用.
- 它讨论了酶降解途径和修改技术.
主要成果:
- NPY家族 (NPY,PYY,PP) 调节食欲并影响胰腺β细胞的存活率.
- 这些在管理肥胖和T2DM方面具有潜在的应用.
- 内源NPY,PYY和PP被二基酶4 (DPP-4) 快速降解,限制了它们的体内半衰期.
结论:
- NPY家族代表了对代谢疾病的有前途的非类疗法.
- 结构修改对于提高NPY,PYY和PP的稳定性和有效性至关重要.
- 需要进一步的研究才能充分将其治疗潜力转化为人类临床环境.
相关概念视频
Regulation of Food Intake
220
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
220
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Diabetes: Management and Pharmacotherapy
260
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
260
Glucagon-like Receptor Agonists
316
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
316
Oral Hypoglycemic Agents: Biguanides and Glitazones
189
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
189
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K


